-
1
-
-
17644399794
-
Drug treatment modalities in psychiatric inpatient practice: A 20-year comparison
-
Barbui C, Ciuna A, Nose M, Levi D, Andretta M, Patten SB, et al. (2005). Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison. Eur Arch Psychiatry Clin Neurosci 255:136-142.
-
(2005)
Eur Arch Psychiatry Clin Neurosci
, vol.255
, pp. 136-142
-
-
Barbui, C.1
Ciuna, A.2
Nose, M.3
Levi, D.4
Andretta, M.5
Patten, S.B.6
-
2
-
-
33749326014
-
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries
-
Barbui C, Nose M, Mazzi MA, Thornicroft G, Schene A, Becker T, et al. (2006). Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. Int Clin Psychopharmacol 21:355-362.
-
(2006)
Int Clin Psychopharmacol
, vol.21
, pp. 355-362
-
-
Barbui, C.1
Nose, M.2
Mazzi, M.A.3
Thornicroft, G.4
Schene, A.5
Becker, T.6
-
3
-
-
26944460800
-
Determinants of antipsychotic polypharmacy in psychiatric inpatients: A prospective study
-
Biancosino B, Barbui C, Marmai L, Dona S, Grassi L (2005). Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study. Int Clin Psychopharmacol 20:305-309.
-
(2005)
Int Clin Psychopharmacol
, vol.20
, pp. 305-309
-
-
Biancosino, B.1
Barbui, C.2
Marmai, L.3
Dona, S.4
Grassi, L.5
-
4
-
-
6344280988
-
Patient opinions on the benefits of treatment programs in residential psychiatric care
-
Biancosino B, Barbui C, Pera V, Osti M, Rocchi D, Marmai L, Grassi L (2004). Patient opinions on the benefits of treatment programs in residential psychiatric care. Can J Psychiatry 49:613-620.
-
(2004)
Can J Psychiatry
, vol.49
, pp. 613-620
-
-
Biancosino, B.1
Barbui, C.2
Pera, V.3
Osti, M.4
Rocchi, D.5
Marmai, L.6
Grassi, L.7
-
5
-
-
33644769548
-
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy
-
Carnahan RM, Lund BC, Perry PJ, Chrischilles EA (2006). Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatr Scand 113:135-141.
-
(2006)
Acta Psychiatr Scand
, vol.113
, pp. 135-141
-
-
Carnahan, R.M.1
Lund, B.C.2
Perry, P.J.3
Chrischilles, E.A.4
-
6
-
-
0036844144
-
Inpatient antipsychotic drug use in 1998, 1993, and 1989
-
Centorrino F, Eakin M, Bahk WM, Kelleher JP, Goren J, Salvatore P, et al. (2002). Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am. J Psychiatry 159:1932-1935.
-
(2002)
Am. J Psychiatry
, vol.159
, pp. 1932-1935
-
-
Centorrino, F.1
Eakin, M.2
Bahk, W.M.3
Kelleher, J.P.4
Goren, J.5
Salvatore, P.6
-
7
-
-
27144462032
-
Use of combinations of antipsychotics: McLean hospital inpatients, 2002
-
Centorrino F, Fogarty KV, Sani G, Salvatore P, Cincotta SL, Hennen J, et al. (2005). Use of combinations of antipsychotics: McLean hospital inpatients, 2002. Hum Psychopharmacol 20:485-492.
-
(2005)
Hum Psychopharmacol
, vol.20
, pp. 485-492
-
-
Centorrino, F.1
Fogarty, K.V.2
Sani, G.3
Salvatore, P.4
Cincotta, S.L.5
Hennen, J.6
-
8
-
-
1842533044
-
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefits
-
Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ (2004). Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 161:700-706.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 700-706
-
-
Centorrino, F.1
Goren, J.L.2
Hennen, J.3
Salvatore, P.4
Kelleher, J.P.5
Baldessarini, R.J.6
-
9
-
-
0036856290
-
Excessive antipsychotic dosing in 2 U.S. State hospitals
-
Diaz FJ, De LJ (2002). Excessive antipsychotic dosing in 2 U.S. State hospitals. J Clin Psychiatry 63:998-1003.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 998-1003
-
-
Diaz, F.J.1
LJ, D.2
-
10
-
-
0037989711
-
Antipsychotic dosing and concurrent psychotropic treatments for medicaid-insured individuals with schizophrenia
-
DosReis S, Zito JM, Buchanan RW, Lehman AF (2002). Antipsychotic dosing and concurrent psychotropic treatments for medicaid-insured individuals with schizophrenia. Schizophr Bull 28:607-617.
-
(2002)
Schizophr Bull
, vol.28
, pp. 607-617
-
-
DosReis, S.1
Zito, J.M.2
Buchanan, R.W.3
Lehman, A.F.4
-
11
-
-
31644445836
-
Schizophrenia, neuroleptic medication and mortality
-
Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V (2006). Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry 188:122-127.
-
(2006)
Br J Psychiatry
, vol.188
, pp. 122-127
-
-
Joukamaa, M.1
Heliovaara, M.2
Knekt, P.3
Aromaa, A.4
Raitasalo, R.5
Lehtinen, V.6
-
12
-
-
0030299883
-
Antipsychotic drug: A study of the prescription pattern in a total sample of patients with a schizophrenic syndrome in one catchment area in the county of Uppland, Sweden, in 1991
-
Lindstrom E, Widerlov B, von KL (1996). Antipsychotic drug: a study of the prescription pattern in a total sample of patients with a schizophrenic syndrome in one catchment area in the county of Uppland, Sweden, in 1991. Int Clin Psychopharmacol 11:241-246.
-
(1996)
Int Clin Psychopharmacol
, vol.11
, pp. 241-246
-
-
Lindstrom, E.1
Widerlov, B.2
von, K.L.3
-
14
-
-
20444449202
-
Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa
-
Patterson BD, Swingler D, Willows S (2005). Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa. Schizophr Res 76:89-97.
-
(2005)
Schizophr Res
, vol.76
, pp. 89-97
-
-
Patterson, B.D.1
Swingler, D.2
Willows, S.3
-
16
-
-
0032711704
-
Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders
-
Tognoni G (1999). Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders. Eur J Clin Pharmacol 55:685-690.
-
(1999)
Eur J Clin Pharmacol
, vol.55
, pp. 685-690
-
-
Tognoni, G.1
-
17
-
-
0031668084
-
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study
-
Waddington JL, Youssef HA, Kinsella A (1998). Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 173:325-329.
-
(1998)
Br J Psychiatry
, vol.173
, pp. 325-329
-
-
Waddington, J.L.1
Youssef, H.A.2
Kinsella, A.3
-
18
-
-
0034121854
-
Patients with schizophrenia at risk for excessive antipsychotic dosing
-
Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S (2000). Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry 61:344-348.
-
(2000)
J Clin Psychiatry
, vol.61
, pp. 344-348
-
-
Walkup, J.T.1
McAlpine, D.D.2
Olfson, M.3
Labay, L.E.4
Boyer, C.5
Hansell, S.6
-
19
-
-
0004100812
-
-
WHO Collaborating Centre for Drug Statistic Methodology , Oslo: WHO Collaborating Centre for Drug Statistic Methodology edn. WHO
-
WHO Collaborating Centre for Drug Statistic Methodology (2003). Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistic Methodology edn. WHO.
-
(2003)
Guidelines for ATC classification and DDD assignment
-
-
|